Logo image of AMLI

AMERICAN LITHIUM CORP (AMLI) Stock Fundamental Analysis

NASDAQ:AMLI - CA0272592092 - Common Stock

0.3752 USD
+0.01 (+3.65%)
Last: 12/27/2024, 8:03:06 PM
0.375 USD
0 (-0.05%)
After Hours: 12/27/2024, 8:03:06 PM
Fundamental Rating

2

Overall AMLI gets a fundamental rating of 2 out of 10. We evaluated AMLI against 156 industry peers in the Metals & Mining industry. The financial health of AMLI is average, but there are quite some concerns on its profitability. AMLI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AMLI had negative earnings in the past year.
AMLI had a negative operating cash flow in the past year.
In the past 5 years AMLI always reported negative net income.
AMLI had a negative operating cash flow in each of the past 5 years.
AMLI Yearly Net Income VS EBIT VS OCF VS FCFAMLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

The Return On Assets of AMLI (-19.16%) is worse than 77.70% of its industry peers.
AMLI has a Return On Equity of -19.52%. This is in the lower half of the industry: AMLI underperforms 71.62% of its industry peers.
Industry RankSector Rank
ROA -19.16%
ROE -19.52%
ROIC N/A
ROA(3y)-17.84%
ROA(5y)-176.28%
ROE(3y)-18.15%
ROE(5y)-275.43%
ROIC(3y)N/A
ROIC(5y)N/A
AMLI Yearly ROA, ROE, ROICAMLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMLI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMLI Yearly Profit, Operating, Gross MarginsAMLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

The number of shares outstanding for AMLI has been increased compared to 1 year ago.
The number of shares outstanding for AMLI has been increased compared to 5 years ago.
The debt/assets ratio for AMLI has been reduced compared to a year ago.
AMLI Yearly Shares OutstandingAMLI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AMLI Yearly Total Debt VS Total AssetsAMLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

AMLI has an Altman-Z score of 22.45. This indicates that AMLI is financially healthy and has little risk of bankruptcy at the moment.
AMLI's Altman-Z score of 22.45 is amongst the best of the industry. AMLI outperforms 87.16% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that AMLI is not too dependend on debt financing.
AMLI has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. AMLI outperforms 84.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 22.45
ROIC/WACCN/A
WACCN/A
AMLI Yearly LT Debt VS Equity VS FCFAMLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 4.22 indicates that AMLI has no problem at all paying its short term obligations.
AMLI has a Current ratio of 4.22. This is in the better half of the industry: AMLI outperforms 75.68% of its industry peers.
AMLI has a Quick Ratio of 4.22. This indicates that AMLI is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 4.22, AMLI is doing good in the industry, outperforming 78.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.22
Quick Ratio 4.22
AMLI Yearly Current Assets VS Current LiabilitesAMLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

1

3. Growth

3.1 Past

AMLI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.74%, which is quite good.
EPS 1Y (TTM)17.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.26%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

AMLI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.88% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y46.32%
EPS Next 2Y24.25%
EPS Next 3Y12.88%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMLI Yearly EPS VS EstimatesAMLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AMLI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMLI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMLI Price Earnings VS Forward Price EarningsAMLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMLI Per share dataAMLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as AMLI's earnings are expected to grow with 12.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.25%
EPS Next 3Y12.88%

More info and screens

0

5. Dividend

5.1 Amount

AMLI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAN LITHIUM CORP

NASDAQ:AMLI (12/27/2024, 8:03:06 PM)

After market: 0.375 0 (-0.05%)

0.3752

+0.01 (+3.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)10-31 2024-10-31/amc
Earnings (Next)N/A N/A
Inst Owners8.38%
Inst Owner ChangeN/A
Ins Owners4.23%
Ins Owner ChangeN/A
Market Cap81.77M
Analysts86.67
Price Target3.13 (734.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.1%
PT rev (3m)-4.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)44.44%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 0.74
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.51
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -19.16%
ROE -19.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-17.84%
ROA(5y)-176.28%
ROE(3y)-18.15%
ROE(5y)-275.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.22
Quick Ratio 4.22
Altman-Z 22.45
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)2061.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.26%
EPS Next Y46.32%
EPS Next 2Y24.25%
EPS Next 3Y12.88%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year25.08%
EBIT Next 3Y-6.13%
EBIT Next 5YN/A
FCF growth 1Y26.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.39%
OCF growth 3YN/A
OCF growth 5YN/A